Augmentation of the Antidepressant Action of Sertraline With Triiodothyronine (T3)and Reboxetine: Clinical Efficacy, Adverse Effects and Predictors of Response.

NCT00421369 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

35

Enrollment

OTHER

Sponsor class

Conditions

Major Depressive Disorder

Interventions

DRUG: sertraline
DRUG: triiodothyronine (T3)
DRUG: reboxetine

Sponsor

Hadassah Medical Organization